246
Views
32
CrossRef citations to date
0
Altmetric
Special Report

Control of hepatitis B in China: prevention and treatment

&
Pages 21-25 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Jingyi Dai, Jun Zhao, Yingrong Du, Edward B McNeil & Virasakdi Chongsuvivatwong. (2019) Biomarkers and sociodemographic factors predicting one-year readmission among liver cirrhosis patients. Therapeutics and Clinical Risk Management 15, pages 979-989.
Read now
Haoping Xu, Xin Zhang, Lu Liu & Jianqiao Hong. (2017) Value effect of rival innovation failure: competition or contagion?. China Journal of Accounting Studies 5:4, pages 449-467.
Read now
Xueyan Liao & Zhenglun Liang. (2015) Strategy vaccination against Hepatitis B in China. Human Vaccines & Immunotherapeutics 11:6, pages 1534-1539.
Read now

Articles from other publishers (29)

Yong-Bin Wang, Si-Yu Qing, Zi-Yue Liang, Chang Ma, Yi-Chun Bai & Chun-Jie Xu. (2023) Time series analysis-based seasonal autoregressive fractionally integrated moving average to estimate hepatitis B and C epidemics in China. World Journal of Gastroenterology 29:42, pages 5716-5727.
Crossref
Bo Zheng, Zexuan Wen, Jinhua Pan & Weibing Wang. (2021) Epidemiologic trends of hepatitis A in different age groups and regions of China from 1990 to 2018: observational population-based study. Epidemiology and Infection 149.
Crossref
Chenzhi Hou, Zhendong Hua, Peng Xu, Hui Xu, Youmei Wang, Jun Liao & Bin Di. (2020) Estimating the prevalence of hepatitis B by wastewater-based epidemiology in 19 cities in China. Science of The Total Environment 740, pages 139696.
Crossref
Shan Shan, Wei Wei, Yuanyuan Kong, Junqi Niu, Jia Shang, Wen Xie, Yuexin Zhang, Hong Ren, Hong Tang, Huiguo Ding, Yuemin Nan, Xiaoguang Dou, Tao Han, Xiaoyuan Xu, Zhongping Duan, Lai Wei, Jinlin Hou, Hui Zhuang, Hong You & Jidong Jia. (2018) China Registry of Hepatitis B (CR-HepB): Protocol and implementation of a nationwide hospital-based registry of hepatitis B. Scandinavian Journal of Public Health 48:2, pages 233-239.
Crossref
Yifei Tan, Xiaoyun Zhang, Wei Zhang, Li Tang, Hanwei Yang, Ke Yan, Li Jiang, Jian Yang, Chuan Li, Jiayin Yang, Tianfu Wen, Huairong Tang & Lunan Yan. (2019) The Influence of Metabolic Syndrome on the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Infection in Mainland China. Cancer Epidemiology, Biomarkers & Prevention 28:12, pages 2038-2046.
Crossref
Shishen Wang, Yuhui Tao, Yuchun Tao, Jing Jiang, Li Yan, Chong Wang, Yaxuan Ding, Jianxing Yu, Dinghui Zhao, Xiumei Chi, Xiaomei Wang, Ruihong Wu, Xiuzhu Gao, Ying Shi, Yazhe Guan, Yingchun Li, Yanli Xing, Haiyan Sun, Changhua Ta, Chao Wang, Junqi Niu, Jing Meng & Hongqin Xu. (2018) Epidemiological study of hepatitis B and hepatitis C infections in Northeastern China and the beneficial effect of the vaccination strategy for hepatitis B: a cross-sectional study. BMC Public Health 18:1.
Crossref
J. Huang, Q. You, D. Song, X. Rong, C. Li & Y. Fu. (2018) Update on epidemiology of hepatitis B virus among blood donors in China. ISBT Science Series 13:3, pages 359-364.
Crossref
Shan Shan, Fuqian Cui & Jidong Jia. (2018) How to control highly endemic hepatitis B in Asia. Liver International 38, pages 122-125.
Crossref
Rong Liang, Yan Lin, Chun-Ling Yuan, Zhi-Hui Liu, Yong-Qiang Li, Xiao-Ling Luo, Jia-Zhou Ye & Hai-Hong Ye. (2017) The clinical significance and biological function of large tumour suppressor 2 in hepatocellular carcinoma. Cell Proliferation 50:3, pages e12340.
Crossref
Jiaxin Huang, Mary L. Guan, Jeremy Balch, Elizabeth Wu, Huiying Rao, Andy Lin, Lai Wei & Anna S. Lok. (2016) Survey of hepatitis B knowledge and stigma among chronically infected patients and uninfected persons in Beijing, China. Liver International 36:11, pages 1595-1603.
Crossref
Tianyu He & Jidong Jia. (2016) Chronic HBV: which pregnant women should be treated?. Liver International 36, pages 105-108.
Crossref
Yan Yang, Ming Yan, Meng Yue, Xiaohua Wang, Wei Zhang, Jie Li & Shuqing Li. (2015) Prevalence of Hepatitis B and Knowledge About Hepatitis B Among Migrant Workers in Shandong Province, China: A Cross-Sectional Study. Iranian Red Crescent Medical Journal 17:4.
Crossref
Jianping Zuo, Wei Tang & Yibin Xu. 2015. Coffee in Health and Disease Prevention. Coffee in Health and Disease Prevention 607 613 .
Guihua Zhuang, Min Zhang, Yong Liu, Yaling Guo, Qian Wu, Kaina Zhou, Zhenhao Ji & Xiaomei Zhang. (2014) Significant impairment of health-related quality of life in mainland Chinese patients with chronic hepatitis B: a cross-sectional survey with pair-matched healthy controls. Health and Quality of Life Outcomes 12:1, pages 101.
Crossref
Mingshun Zhang, Guohong Ge, Yonglin Yang, Xubing Cai, Qiang Fu, Jie Cai & Zuhu Huang. (2013) Decreased antigenicity profiles of immune-escaped and drug-resistant hepatitis B surface antigen (HBsAg) double mutants. Virology Journal 10:1.
Crossref
Wang Hongfei, Zhao Yunyan, Yan Fei & Liu Hui. (2013) Evaluation of an artificial neural network to ascertain why there is a high incidence of hepatitis B in the Chinese population after vaccination. Computers in Biology and Medicine 43:9, pages 1167-1170.
Crossref
Tonghai Xing, Li Huang, Zhenhai Yu, Lin Zhong, Shuyun Wang & Zhihai Peng. (2013) Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma. PLoS ONE 8:8, pages e71251.
Crossref
Yan Cui & Jidong Jia. (2013) Update on epidemiology of hepatitis B and C in China. Journal of Gastroenterology and Hepatology 28, pages 7-10.
Crossref
Qiang YuChunxiao ZhouJian WangLei ChenShudan ZhengJinkun Zhang. (2013) A Functional Insertion/Deletion Polymorphism in the Promoter of PDCD6IP Is Associated with the Susceptibility of Hepatocellular Carcinoma in a Chinese Population . DNA and Cell Biology 32:8, pages 451-457.
Crossref
Xilin Yang, Ying Wang, Andrea O Y Luk, Wing Yee So, Ronald C W Ma, Alice P S Kong, Gang Xu & Juliana C N Chan. (2013) Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes. Endocrine-Related Cancer 20:2, pages 161-171.
Crossref
J. Jia. (2013) A different look at the management of chronic hepatitis B in a resource-constrained country. Journal of Viral Hepatitis 20, pages 1-1.
Crossref
Hong Ma & Jidong Jia. (2013) Why do I treat HBeAg-positive chronic hepatitis B patients with a Nucleoside analogue. Liver International 33, pages 133-136.
Crossref
Yang Yong-lin, Fu Qiang, Zhang Ming-shun, Cai Jie, Ma Gui-ming, Huang Zu-hu & Cai Xu-bing. (2012) Hepatitis B surface antigen variants in voluntary blood donors in Nanjing, China. Virology Journal 9:1.
Crossref
Yao Zhang, Hua Zhang, Au Elizabeth & Xiao-qing Liu. (2012) Epidemiology of Hepatitis B and Associated Liver Diseases in China. Chinese Medical Sciences Journal 27:4, pages 243-248.
Crossref
Yiqi JinQiang YuDayong ZhouLei ChenXianchen HuangGuoxiong XuJian HuangXueren GaoYuzhen GaoLiming Shen. (2012) The Mitochondrial DNA 9-bp Deletion Polymorphism Is a Risk Factor for Hepatocellular Carcinoma in the Chinese Population. Genetic Testing and Molecular Biomarkers 16:5, pages 330-334.
Crossref
Yao Liu, Shandong Pan, Li Liu, Xiangjun Zhai, Jibin Liu, Juan Wen, Yixin Zhang, Jianguo Chen, Hongbing Shen & Zhibin Hu. (2012) A Genetic Variant in Long Non-Coding RNA HULC Contributes to Risk of HBV-Related Hepatocellular Carcinoma in a Chinese Population. PLoS ONE 7:4, pages e35145.
Crossref
Xue-Ping NanYe ZhangHai-Tao YuRui-Lin SunMei-Juan PengYu LiWen-Jing SuJian-Qi LianJiu-Ping WangXue-Fan Bai. (2012) Inhibition of Viral Replication Downregulates CD4 + CD25 high Regulatory T Cells and Programmed Death-Ligand 1 in Chronic Hepatitis B . Viral Immunology 25:1, pages 21-28.
Crossref
Tianhai Tian. (2011) Stochastic dynamics of a Hepatitis B virus transmission model. Stochastic dynamics of a Hepatitis B virus transmission model.
Li Jiang, Lunan Yan, Bo Li, Tianfu Wen, Jichun Zhao, Lisheng Jiang, Jiayin Yang, Mingqing Xu & Wentao Wang. (2011) Successful use of hepatitis B surface antigen-positive liver grafts in recipients with hepatitis B virus-related liver diseases. Liver Transplantation 17:10, pages 1236-1238.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.